期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (1)
Objective: To investigate the applicability of carboxymethyl starch (CMS) as a carrier to prepare solid dispersions (SDs) of piperine (PIP) and 18 bet......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (1)
ContextThe purpose of this study was to prepare enteric-coated particles based on albumin nanoparticles (NPs) using a mixture of PIA albumin NPs freez......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; ()
Antihypertensive treatment reduces the risk of cardiovascular complications in patients with high mortality with hypertension. Valsartan is highly sel......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; ()
ObjectiveBreast cancer affects women globally, regardless of age or location. On the other hand, Tamoxifen (TXN), a class II biopharmaceutical drug is......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (1)
Due to the complexity of the pathophysiology of non-small cell lung cancer (NSCLC) and the susceptibility of single chemotherapy to drug resistance, t......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (10)
BackgroundKaempferol, the natural bioactive flavonoid, has been utilized as an efficient anti-breast cancer compound. In the current study, the Kaempf......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (2)
ObjectiveIn the present study, an attempt has been made to develop SL-loaded transfersomal gel for the effective treatment of delayed wound healing.Si......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (3)
ObjectiveWe evaluated the DNA nanocarriers synthesized by rolling circle amplification (RCA), composed of multiple repeats of AS1411 and FOXM1 aptamer......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (8)
ObjectiveArsenic trioxide (ATO) exerts therapeutic effects on various solid tumors, and artesunate (ART) synergizes with antitumor drugs. We herein co......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (10)
Objective: The manuscript aims to prepare and comprehensively characterize curcumin-loaded chitosan-hyaluronic acid polyelectrolyte complex (PEC) hydr......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (1)
ObjectiveThe present work provides characterization of rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray (AM-301), ......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (1)
Objective: To evaluate the possible application of Sangelose as an alternative to gelatin and carrageenan for the development of film substrates, and ......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (1)
PurposeTo counteract early morning pathology like hypertension a time-dependent release of the drug is required. This study is focused to formulate a ......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (3)
BackgroundGinkgo biloba (GB) leaves extract is known to possess potent antioxidants and other bioactivities such as improved skin conditions and rejuv......
期刊： DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023; 49 (6)
BackgroundInfluenza caused by the H1N1 virus still affects human health. There is currently no effective strategy against H1N1 virus infection. The pr......
